Theriva Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.22

0.00 (-1.86%)

As of Sep 28, 10:42 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +17,789.1% upside

Low Target $26.34

Average Target $38.73

High Target $46.19

Current Price $0.22

Current
$0.22

Target
$38.73

$26.34 $38.73 avg $46.19

Scenario Analysis

Bear Case

$26.34

12,066.3%

Low target

Base Case

$38.73

+17,789.1%

Avg target

Bull Case

$46.19

+21,234.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$0.86

-74.9% from high

52-Week Low

$0.16

+33.0% from low

Target vs 52W High

$38.73

+4,386.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%